HPV vaccine received well in China market

YINCHUAN - Fan Lei, 32, can't wait to get her first human papilloma virus vaccine after a fretful three-month wait.

"I asked for leave immediately after the call from the community health service center," she said.

The HPV vaccine she received in Yinchuan, Ningxia Hui autonomous region, was developed by US-based Merck and approved by the China Food and Drug Administration to enter the market in May. The first batch reached Chinese consumers a month ago.